References
- Sakurai, T. and Tsuchiya, S. (1988) Superoxide production from nonenzymatically glycated protein. FEBS Lett. 236: 406-410 https://doi.org/10.1016/0014-5793(88)80066-8
- Shinohara, R., Mano, T., Nagasaka, A, Sawai, Y, Uchimura, K., Hayashi, R., Hayakawa, N., Nagata, M., Makino, M., Kakizawa, H., Ttoh, Y, Nakai, A and Itoh, M. (1998) Effects of thyroid honnone on the sorbitol pathway in streptozotocin- induced diabetic rats. Biochim. Biophys. Acta 1425: 577-586 https://doi.org/10.1016/S0304-4165(98)00111-1
- Larkins, R.G and Dunlop, M.E. (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35: 499-504 https://doi.org/10.1007/BF00400475
- Forbes, J.M., Cooper, M.E., Oldfield, M.D. and Thomas, M.C. (2003) Role ofadvanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14: S254-S258 https://doi.org/10.1097/01.ASN.0000077413.41276.17
- Bierhaus, A., Hofmann M.A., Ziegler, R. and Nawroth, P. (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetic mellitus. I. The AGE concept Cardiovasc. Res. 37: 586-600 https://doi.org/10.1016/S0008-6363(97)00233-2
- Brownlee, M. (1996) Advanced glycation endproducts in diabetic complications. Curr. Opinion Endocrinol Diabetes 3: 291-297 https://doi.org/10.1097/00060793-199608000-00003
- Rahbar, S. and Figarola, J.L. (2003) Novel inhibitors of advanced glycation endproducts. Arch. Biochem. Biophys. 419: 63-79 https://doi.org/10.1016/j.abb.2003.08.009
- Yokozawa, T., Nakagawa, T. and Terasawa, K. (2001) Effects of Oriental medicines on the production of advanced glycation endproducts. J. Trad Med. 18: 107-112
- Kim, J.S., Kim, H. and Ko, J.H. (2002) Studies on the processing of herbal medicines (III)-HPLC analysis ofmagnolol and inhibitory effects on the formation ofadvanced glycation endproducts (AGEs) in vitro of unprocessed and processed Magnolia Bark. Kor. J. Pharmacogn. 33: 308-311
- Vinson, J.A. and Howard III, T.B (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr. Biochem. 7: 659-663 https://doi.org/10.1016/S0955-2863(96)00128-3
- Nakagawa, T., Yokozawa, T. and Terasawa, K. (2001) A study ofKampo medicines in a diabetic nephropathy model. J. Trad Med 18: 161-168
- 김호철 (2001) 한약약리학, 309 집문당. 서울
- 생약학연구회 (1995) 현대생약학, 218, 학창사, 서울
- 생약학연구회 (1995) 현대생약학, 137, 학창사, 서울
- 생약학연구회 (1995) 현대생약학, 144, 학창사, 서울
- 김호철 (2001) 한약약리학 , 332. 집문당. 서울
- 김호철 (2001) 한약약리학 , 297. 집문당. 서울
- 생약학연구회 (1995) 현대생약학 154.학창사. 서울
- 김호철 (2001) 한약약리학 , 234. 집문당. 서울
- Matsuda, H., Wang, T., Managi, H. and Yoshikawa, M. (2003) Structural requirements offlavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 11: 5317-5323 https://doi.org/10.1016/j.bmc.2003.09.045
- Jung, Y.S., Joe, R.Y, Cho, S.J. and Konishi, Y. (2005) 2,3-Dimethoxy- 5-methyl-1,4-benzoquinones and 2-methyl-1,4naphthoquinones: Glycation inhibitors with lipid peroxidation activity. Bioorg. Med. Chem. 15: 1125-1129 https://doi.org/10.1016/j.bmcl.2004.12.029